At the rate things are going, maybe by Thanksgivin
Post# of 148155
I love how NP continually defends the FDA and I understand why he does so. Obviously he has to stay in their good graces. But the argument of trial protocol etc. is infuriating when one considers Leronlimab's safety profile, the data we already have, anecdotal evidence, AND THE FACT THAT 2000+ AMERICANS ARE DYING DAILY.
These are not normal times FFS. This is a global pandemic. So I won't give the FDA credit for expediting a process from years to months, when it should be weeks.